Matthew Baker M.D., M.S.

168 posts

Matthew Baker M.D., M.S. banner
Matthew Baker M.D., M.S.

Matthew Baker M.D., M.S.

@mbake013

Rheumatologist, Clinical Trialist, and Epi Researcher studying #Sarcoidosis, #IgG4RD, #Sjogrens, #RA. Associate Division Chief of Rheumatology @StanfordDeptMed

Stanford, CA Katılım Ekim 2017
1.2K Takip Edilen528 Takipçiler
Matthew Baker M.D., M.S. retweetledi
Stanford Rheumatology
Stanford Rheumatology@StanfordRheum·
Such a wonderful evening getting together for the Division of Immunology and Rheumatology Holiday Party! 🎉 🎄 We are excited for a collaborative and productive 2025!
Stanford Rheumatology tweet mediaStanford Rheumatology tweet mediaStanford Rheumatology tweet mediaStanford Rheumatology tweet media
English
0
2
17
1.4K
Matthew Baker M.D., M.S.
Matthew Baker M.D., M.S.@mbake013·
@itchdoctor What do you think the implications of this are for all the migraines patients on anti-CGRP therapies (i.e., reduced ability to combat viral infections)?
English
1
0
1
139
Matthew Baker M.D., M.S. retweetledi
Stanford Department of Medicine
Stanford Department of Medicine@StanfordDeptMed·
We are thrilled to announce our new Chair of the Stanford Department of Medicine, Dr. Euan Ashley @euanashley . We have a great future ahead!!! Dr. Ashley becomes Chair Sept 18th, 2024.
Stanford Department of Medicine tweet media
English
38
33
317
68K
Matthew Baker M.D., M.S. retweetledi
Zach Wallace
Zach Wallace@zach_wallace_md·
Inebilizumab hit its primary and key secondary endpoints for #IgG4RD. Huge moment for the IgG4-RD community! Looking forward to full results. wwwext.amgen.com/newsroom/press…..
English
2
18
40
3.8K
Matthew Baker M.D., M.S. retweetledi
J. Sawalla Guseh, M.D.
J. Sawalla Guseh, M.D.@JSawallaGusehMD·
This day, now a decade ago. 👇🏾 December 20, 2013 Senior Assistant Residents Department of Medicine Massachusetts General Hospital CC: @mghmedres
J. Sawalla Guseh, M.D. tweet media
Boston, MA 🇺🇸 English
4
5
72
7.9K
Matthew Baker M.D., M.S. retweetledi
Steven Zhao
Steven Zhao@SteZhao·
A recent small placebo-cont'd #RCT of IL6R inhibitor #sarilumab for #sarcoidosis found no benefit despite plausible biology. Is a larger RCT needed? Can we predict what that RCT might find? 🚨Human genetic data do 𝐧𝐨𝐭 support IL6Ri for sarcoidosis academic.oup.com/rheumatology/a…
English
2
12
32
7.8K
Matthew Baker M.D., M.S.
Matthew Baker M.D., M.S.@mbake013·
Such a fun and memorable #ACR2023. Great to catch up with old friends and meet new collaborators!
Matthew Baker M.D., M.S. tweet mediaMatthew Baker M.D., M.S. tweet mediaMatthew Baker M.D., M.S. tweet mediaMatthew Baker M.D., M.S. tweet media
San Diego, CA 🇺🇸 English
0
1
17
1.6K
Matthew Baker M.D., M.S. retweetledi
Jeffrey Sparks MD MMSc
Jeffrey Sparks MD MMSc@jeffsparks·
Impressive and important study supporting safety of TNF inhibitors among patients with RA-ILD. Elegant methods of target trial emulation. Congrats to the authors on plenary presentation! #ACR23
Jeffrey Sparks MD MMSc tweet mediaJeffrey Sparks MD MMSc tweet media
English
1
11
54
3.7K
Matthew Baker M.D., M.S. retweetledi
J. Sawalla Guseh, M.D.
J. Sawalla Guseh, M.D.@JSawallaGusehMD·
When Einthoven introduced the ECG to the world, he uniquely labeled its parts PQRST, inspired by mathematicians who used Ps & Qs in coordinates. Yet, he believed there was more to find, so he started in the alphabet's middle, leaving room for new discoveries on both sides. 1/n
J. Sawalla Guseh, M.D. tweet media
English
9
138
596
139.9K